AKER - エイカ―ズ・バイオサイエンス (Akers Biosciences Inc) エイカ―ズ・バイオサイエンス

 AKERのチャート


 AKERの企業情報

symbol AKER
会社名 Akers Biosciences Inc (エイカ―ズ・バイオサイエンス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: In Vitro_In Vivo Diagnostic Substances  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Akers Biosciences Inc. develops manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company''s product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties including cardiology/emergency medicine metabolism/nutrition diabetes respiratory diseases and infectious diseases detection as well as for on and off-the-job alcohol safety initiatives. The Company''s primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes to facilitate time sensitive therapeutic decisions. The Company''s main products include a disposable breathalyzer test that measures the blood alcohol content of the user a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.   エイカ―ズ・バイオサイエンスは米国の医療テスト製品メ―カ―。ポイント・オブ・ケアのスクリ―ニングやテスト製品の開発、製造を行う。主力製品は、血中アルコ―ル含有量の測定をする使い捨ての飲酒検査、人間の体内でフリ―ラジカル活性を測定する使い捨て飲酒検査、ヘパリンに対するアレルギ―反応を引き起こす抗体を検出する迅速試験など。   
本社所在地 201 Grove Road Thorofare NJ 08086 USA
代表者氏名 Howard R. Yeaton ハワード・R・イートン
代表者役職名 Chief Executive Officer
電話番号 +1 856-848-8698
設立年月日 2005年
市場名 NASDAQ Small Cap
ipoyear 2014年
従業員数 32人
url www.akersbio.com
nasdaq_url https://www.nasdaq.com/symbol/aker
adr_tso
EBITDA EBITDA(百万ドル) -8.19618
終値(lastsale) 0.3582
時価総額(marketcap) 33708873.7944
時価総額 時価総額(百万ドル) 33.31363
売上高 売上高(百万ドル) 2.44368
企業価値(EV) 企業価値(EV)(百万ドル) 25.06009
当期純利益 当期純利益(百万ドル) -9.12646
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Akers Biosciences Inc revenues decreased 52% to $829K. Net loss increased 81% to $3.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Administrative Expenses increase of 53% to $2.5M (expense) Research and Development Expenses - Rela increase from $23K to $54K (expense).

 AKERのテクニカル分析


 AKERのニュース

   SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations  2020/12/11 01:37:00 PR Newswire
NEW YORK, Dec. 10, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor…
   ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm  2020/12/05 13:30:00 PR Newswire
NEW YORK, Dec. 5, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following mergers: Inphi Corporation (NASDAQ: IPHI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to…
   AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER  2020/12/03 18:16:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Akers Biosciences, Inc. (NasdaqCM: AKER) with MyMD Pharmaceuticals, Inc., pursuant to which Akers shareholders will end up owning just 20% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you
   Why These 4 Pharma Stocks Are Moving Today  2020/12/02 12:13:00 Benzinga
Akers Biosciences (NASDAQ: AKER) shares are trading higher on Wednesday after the company's proposed merger partner MyMD Pharmaceuticals released news. …
   Aker BP and Cognite Pioneer Robotics Deployment Offshore to Transform Oil and Gas Industry with Autonomous Mission  2020/11/24 08:00:00 Business Wire
OSLO, Norway--(BUSINESS WIRE)--Aker BP and Cognite Pioneer Robotics Deployment Offshore to Transform Oil and Gas Industry with Autonomous Mission
   Aker : Carbon Capture AS and Aker Offshore Wind Holding AS – Private Placements Successfully Placed | MarketScreener  2020/08/14 06:13:04 MarketScreener
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER… | August 14, 2020
   Why Akers Biosciences Is Trading Higher Today  2020/07/20 19:05:10 Benzinga Feeds
Akers Biosciences Inc (NASDAQ: AKER ) shares are trading higher … Full story available on Benzinga.com
   Aker : Second-Quarter and Half-Year Results 2020 | MarketScreener  2020/07/15 05:11:16 MarketScreener
2Q 2020 Financial Highlights Revenue NOK 5.4 billion EBITDA NOK 232 million EBITDA ex. special… | July 15, 2020
   Aker : Awarded Letter of Intent for Askeladd Vest | MarketScreener  2020/06/30 14:04:10 MarketScreener
The development of Askeladd Vest is phase two of the multi-phased Snøhvit gas development in the Barents Sea. 'We are pleased to extend the series of… | June 30, 2020
   Aker ASA: Joint Venture with Ocean Yield | MarketScreener  2020/06/11 16:28:05 MarketScreener
Aker has entered into an agreement with Ocean Yield whereby Aker will acquire from Ocean Yield 50% of seven tankers with long-term charters. The Joint Venture will own four LR2… | June 11, 2020
   Aker : Carbon Capture AS and Aker Offshore Wind Holding AS – Private Placements Successfully Placed | MarketScreener  2020/08/14 06:13:04 MarketScreener
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER… | August 14, 2020
   Why Akers Biosciences Is Trading Higher Today  2020/07/20 19:05:10 Benzinga Feeds
Akers Biosciences Inc (NASDAQ: AKER ) shares are trading higher … Full story available on Benzinga.com
   Aker : Second-Quarter and Half-Year Results 2020 | MarketScreener  2020/07/15 05:11:16 MarketScreener
2Q 2020 Financial Highlights Revenue NOK 5.4 billion EBITDA NOK 232 million EBITDA ex. special… | July 15, 2020
   Aker : Awarded Letter of Intent for Askeladd Vest | MarketScreener  2020/06/30 14:04:10 MarketScreener
The development of Askeladd Vest is phase two of the multi-phased Snøhvit gas development in the Barents Sea. 'We are pleased to extend the series of… | June 30, 2020
   Aker ASA: Joint Venture with Ocean Yield | MarketScreener  2020/06/11 16:28:05 MarketScreener
Aker has entered into an agreement with Ocean Yield whereby Aker will acquire from Ocean Yield 50% of seven tankers with long-term charters. The Joint Venture will own four LR2… | June 11, 2020

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エイカ―ズ・バイオサイエンス AKER Akers Biosciences Inc)

 twitter  (公式ツイッターやCEOツイッターなど)